Search information pages
About Clinical Epigenetics
This page includes information about the aims and scope of Clinical Epigenetics, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Clinical Epigenetics, the official journal of the Clinical Epigenetics Society, is an open access, peer-reviewed journal that encompasses all aspects of epigenetic principles and mechanisms in relation to human disease, diagnosis and therapy. Research in disease model organisms is particularly welcome.
Topics of interest include, but are not limited to:
- Epigenetics and disease
- Epigenetics and aging
- Epigenetics in developmental processes
- Epigenomics and pharmacoepigenomics
- Epigenetics, environment, nutrition and evolution
- DNA, histone and chromatin modifications
- Non-coding RNA and gene silencing
Clinical Epigenetics focuses on epigenetic changes in normal and diseased cells in response to internal or external factors with the aim to translate basic epigenetic research into diagnosis, therapy and prevention.
All articles published by Clinical Epigenetics are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Clinical Epigenetics are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Clinical Epigenetics therefore levies an article-processing charge of £1520/$2590/€1920 for each article accepted for publication. If the submitting author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
All articles published in Clinical Epigenetics are included in:
- Academic OneFile
- Journal Citation Reports/Science Edition
- PubMed Central
- Science Citation Index Expanded
- Summon by Serial Solutions
The full text of all research articles published by BioMed Central is also available on SpringerLink.
Clinical Epigenetics is tracked by Thomson Reuters (ISI) and has an Impact Factor of 6.22.
Publication and peer review process
Research: reports of data from original research.
Reviews: comprehensive, authoritative, descriptions of any subject within the scope of the journal.
Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.
Case studies: descriptions of a major programme intervention or policy option relevant to the journal field. Case study articles should include a rigorous assessment of the processes and the impact of the study, as well as recommendations for the future.
Hypotheses: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
Methodology articles: presentations of a new experimental method, test or procedure.
Short reports: brief reports of data from original research.
All submitted manuscripts are evaluated by the Editor-in-Chief and suitable manuscripts are sent for peer review. The reports of at least two reviewers are considered when deciding on acceptance or rejection of a manuscript; a further reviewer is invited in cases where these reviewers disagree. The peer-review system is closed, meaning that reviewer' confidentiality is maintained and reports are not made publicly available. Final decisions, however, rest with the Editor-in-Chief, who aims to provide an initial decision within four weeks.
Edited by Ulrich Mahlknecht, Clinical Epigenetics is supported by an expert Editorial Board.
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Clinical Epigenetics, a personalized section of the site.
Copyediting and proofs
High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.
Clinical Epigenetics will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. For further information, please contact us.
All manuscripts submitted to Clinical Epigenetics should adhere to BioMed Central's editorial policies.
Citing articles in Clinical Epigenetics
Articles in Clinical Epigenetics should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Clin Epigenetics [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Clin Epigenetics 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Clinical Epigenetics?
Clinical Epigenetics's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Clinical Epigenetics offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Clinical Epigenetics and BioMed Central.
Online publication in Clinical Epigenetics gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Clinical Epigenetics are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Clinical Epigenetics's pages and on the BioMed Central homepage.
In addition, articles published in Clinical Epigenetics may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Clinical Epigenetics. A list of articles recently press-released by journals published by BioMed Central is available here.
Authors of articles published in Clinical Epigenetics retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.